Literature DB >> 27686739

The impacts of initial and relative dose intensity of R-CHOP on outcomes of elderly patients with diffuse large B-cell lymphoma.

Yusuke Kanemasa1, Tatsu Shimoyama1, Yuki Sasaki2, Miho Tamura1, Takeshi Sawada1, Yasushi Omuro1, Tsunekazu Hishima3, Yoshiharu Maeda1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27686739     DOI： 10.1080/10428194.2016.1211279

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  5 in total

1.  Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611).

Authors:  Michael Tallarico; Jared C Foster; Drew Seisler; Jacqueline M Lafky; Arti Hurria; Aminah Jatoi; Harvey J Cohen; Hyman B Muss; Nancy Bartlett; Bruce D Cheson; Sin-Ho Jung; John P Leonard; John C Byrd; Chadi Nabhan
Journal:  J Geriatr Oncol       Date:  2018-04-17       Impact factor: 3.599

2.  Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma.

Authors:  Hanno M Witte; Armin Riecke; Thomas Mayer; Tobias Bartscht; Dirk Rades; Hendrik Lehnert; Hartmut Merz; Sebastian Fetscher; Harald Biersack; Niklas Gebauer
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-16       Impact factor: 4.553

3.  3A Comparison between R-THP-COP and R-CHOP Regimens for the Treatment of Diffuse Large B-cell Lymphoma in Old Patients: A Single-institution Analysis.

Authors:  Hiroaki Araie; Ippei Sakamaki; Yasufumi Matsuda; Katsunori Tai; Satoshi Ikegaya; Kazuhiro Itoh; Shinji Kishi; Kana Oiwa; Miyuki Okura; Toshiki Tasaki; Naoko Hosono; Takanori Ueda; Takahiro Yamauchi
Journal:  Intern Med       Date:  2017-08-21       Impact factor: 1.271

4.  The average relative dose intensity of R-CHOP is an independent factor determining favorable overall survival in diffuse large B-cell lymphoma patients.

Authors:  Monika Długosz-Danecka; Sebastian Szmit; Tomasz Ogórka; Aleksander B Skotnicki; Wojciech Jurczak
Journal:  Cancer Med       Date:  2019-02-10       Impact factor: 4.452

5.  Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in England.

Authors:  L Hounsome; T A Eyre; R Ireland; A Hodson; R Walewska; K Ardeshna; S Chaganti; P McKay; A Davies; C P Fox; N Kalakonda; P A Fields
Journal:  Br J Cancer       Date:  2021-10-05       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.